Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.43 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.43 |
| ▸ | KCNH2 | Q12809 | 5/20 | 0.41 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.40 |
| ▸ | SLC2A1 | P11166 | 1/20 | 0.39 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.39 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.39 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.39 |
| ▸ | HTR1A | P08908 | 1/20 | 0.39 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | DRD1 | P21728 | 1/20 | 0.39 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.39 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.39 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28723073 | 1.00 | SIGMAR1 (0.46) | SIGMAR1ALDH1A1HRH4HRH3KCNH2 | |
| SCHEMBL6366393 | 1.00 | SIGMAR1 (0.46) | SIGMAR1ALDH1A1HRH4HRH3KCNH2 | |
| SCHEMBL1313942 | 1.00 | SIGMAR1 (0.46) | SIGMAR1ALDH1A1HRH4HRH3KCNH2 | |
| SCHEMBL2142541 | 1.00 | SIGMAR1 (0.46) | SIGMAR1ALDH1A1HRH4HRH3KCNH2 | |
| SCHEMBL2141035 | 1.00 | SIGMAR1 (0.46) | SIGMAR1ALDH1A1HRH4HRH3KCNH2 | |
| SCHEMBL2137948 | 1.00 | SIGMAR1 (0.46) | SIGMAR1ALDH1A1HRH4HRH3KCNH2 | |
| SCHEMBL757439 | 0.96 | SIGMAR1 (0.44) | SIGMAR1ALDH1A1HRH4HRH3KCNH2 | |
| SCHEMBL5990364 | 0.96 | SIGMAR1 (0.44) | SIGMAR1ALDH1A1HRH4HRH3KCNH2 | |
| SCHEMBL15052279 | 0.96 | SIGMAR1 (0.48) | SIGMAR1ALDH1A1HRH4HRH3KCNH2 | |
| SCHEMBL234338 | 0.96 | SIGMAR1 (0.48) | SIGMAR1ALDH1A1HRH4HRH3KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114276256-A | Polyquaternary ammonium compound and preparation method and application thereof | 安庆北化大科技园有限公司 | 2022-04-05 | — | — | CN | disclosed |
| EP-2785435-B1 | METHOD FOR ELIMINATING ACID COMPOUNDS FROM A GASEOUS EFFLUENT WITH AN ABSORBENT SOLUTION MADE FROM BIS(AMINO-3-PROPYL)ETHERS OR (AMINO-2-ETHYL)-(AMINO-3-PROPYL)ETHERS | IFP ENERGIES NOW (FR) | 2018-02-28 | — | — | EP | disclosed |
| US-8231997-B2 | Electrolyte membrane-electrode membrane assembly for solid polymer fuel cell and production method thereof, and fuel cell equipped therewith | TOKUYAMA CORPORATION (JP) | 2012-07-31 | — | — | US | disclosed |
| EP-1965456-B1 | ELECTROLYTE MEMBRANE-ELECTRODE MEMBRANE ASSEMBLY FOR SOLID POLYMER FUEL CELL, PROCESS FOR PRODUCING THE SAME, AND FUEL CELL COMPRISING SAID ASSEMBLY | TOKUYAMA CORP (JP) | 2011-11-02 | — | — | EP | disclosed |
| US-20090305110-A1 | ELECTROLYTE MEMBRANE-ELECTRODE MEMBRANE ASSEMBLY FOR SOLID POLYMER TYPE FUEL CELL AND PRODUCTION METHOD THEREOF, AND FUEL CELL EQUIPPED THEREWITH | TOKUYAMA CORPORATION (JP) | 2009-12-10 | — | — | US | disclosed |
| EP-1965456-A1 | ELECTROLYTE MEMBRANE-ELECTRODE MEMBRANE ASSEMBLY FOR SOLID POLYMER FUEL CELL, PROCESS FOR PRODUCING THE ELECTROLYTE MEMBRANE-ELECTRODE MEMBRANE ASSEMBLY, AND FUEL CELL COMPRISING THE ELECTROLYTE MEMBRANE-ELECTRODE MEMBRANE ASSEMBLY | TOKUYAMA CORPORATION (JP) | 2008-09-03 | — | — | EP | disclosed |
| US-20060019565-A1 | Method for delivering biologically active substnces | CIBA SPECIALTY CHEMICALS CORP. | 2006-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060019565-A1 | Method for delivering biologically active substnces | DNPEP, MME, DBH | SIGMAR1 205/4885ALDH1A1 268/4885HRH4 762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.